DOOR framework shows similar outcomes in skin infection trials - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

DOOR framework shows similar outcomes in skin infection trials

“Using DOOR can provide clinicians and patients with a better understanding of the benefits and risks of new anti-infectives being studied to treat skin infections.” 

  • By

  • Matthew Solan

  • August 24, 2026

  • 7 min

Share

Clinical Scorecard: DOOR framework shows similar outcomes in skin infection trials

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: DOOR framework shows similar outcomes in skin infection trials
Key MechanismsDesirability of outcome ranking (DOOR) framework evaluates treatment benefits and harms in the context of the trials.
Target PopulationPopulation described in the source article.
Care SettingCare setting described in the source article.

Key Highlights

  • Subgroup analysis indicated a potential benefit of omadacycline in patients with diabetes, but this finding is hypothesis-generating due to the small sample size.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider both omadacycline and linezolid as treatment options based on patient-specific factors, as indicated in the trials.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Participants from OASIS-1 and OASIS-2 trials, totaling 1,347 patients.

        Both treatments were effective, with no significant differences in outcomes.

        Clinical Best Practices

        • Incorporate DOOR framework in future ABSSSI trials for comprehensive outcome assessment, as suggested by the authors.

        Related Resources & Content

        Original Source(s)

        DOOR framework shows similar outcomes in skin infection trials

        • by Matthew Solan

        • August 24, 2026

        Related Content

        Bacterial Pseudaminic Acid Emerges as an Immune Target

        Glycoproteomic mapping reveals pseudaminic acid as a shared feature across pathogenic bacteria 

        • February 18, 2026

        • 2 min
        Caries May Signal Oral Antibiotic Resistance

        Study found species-specific differences in biofilm -forming capacity and antimicrobial susceptibility among supragingival bacterial isolates from patients with active dental caries.

        Side Effects: Four Studies Worth Passing On

        Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.